Study of apoptosis related factors regulatory mechanism of resveratrol to human skin squamous cell carcinoma A431 xenograft in nude mice

National Medical Journal of China

Volumn 93, Issue 6, 2013, Pages 464-468

  Hao, Yu Qin ^a   Huang, Wei Xing ^b   Feng, Hong Xia ^a   Zhang, Guo Hui ^a   Ning, Xiao Hong ^a   Li, Heng Gui ^a   Hao, Chun Guang ^b   Li, Zhe Hai ^a  

^a Third Affiliated Hospital of Inner Mongolian Medical University   (China)

^b NONE

Author keywords

Carcinoma, squamous cell; Caspase 3; Survivin; Veratrum; Xenografts

Indexed keywords

BETA ACTIN; CASPASE 3; CYCLOPHOSPHAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; RESVERATROL; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME INHIBITION; LOW DRUG DOSE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; SKIN CARCINOMA; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, NUDE; SKIN NEOPLASMS; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875294420     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.06.018     Document Type: Article

References (15)

1. Jang M, Cai L, Udeani G O, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275:218-220.
2. Das S, Das D K. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov, 2007, 2:133-138.
3. Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 2004, 305:1010-1013.
4. Fulda S, Debatin K M. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res, 2004, 64:337-346.
5. Zhang Q, Tang X, Lu Q Y, et al. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1 alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther, 2005, 4:1465-1474.
6. Gatouillat G, Balasse E, Joseph-Pietras D, et al. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J Cell Biochem, 2010, 110:893-902.
7. Colin D, Gimazane A, Lizard G, et al. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int J Cancer, 2009, 124:2780-2788.
8. 2009, 30:212-217.
9. Harikumar K B, Kunnumakkara A B, Sethi G, et al. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer, 2010, 127:257-268.
10. Alkhalaf M, El-Mowafy A, Renno W, et al. Resveratrol-induced apoptosis in human breast cancer cells is mediated primarity through the caspase-3-dependent pathway. Arch Med Res, 2008, 39: 162-168.
11. Bhat K P, Pezzuto J M. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci, 2002, 957:210-229.
12. Porebska I, Sobańska E, Kosacka M, et al. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer. Cancer Genomics Proteomics, 2010, 7:331-335.
13. Zhao W, Bao P, Qi H, et al. Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells. Oncol Rep, 2010, 23:279-286.
14. Harikumar K B, Kunnumakkara A B, Sethi G, et al. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer, 2010, 127:257-268.
15. Lu H, Gan M, Zhang G, et al. Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis. Eur J Gynaecol Oncol, 2010, 31:662-666.